Early and Intermediate Outcomes of Cavitron Ultrasonic Surgical Aspiration to Treat Mitral Annular Calcification
European Journal of Cardio-Thoracic Surgery · 2026
DOI: 10.1093/ejcts/ezag016 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2026. Verfasst von Wendy Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery, Hartford Healthcare Heart and Vascular Institute, Hartford, CT, 06106, United States. Hauptthemen laut MEDLINE: Calcinosis, Mitral Valve, Ultrasonic Surgical Procedures, Heart Valve Diseases. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objectives
Severe mitral annular calcification (MAC) carries an increased risk of perioperative complications in patients undergoing mitral valve surgery and may be considered a prohibitive surgical risk. Cavitron ultrasonic surgical aspiration (CUSA) has been reported as a method for controlled debridement of severe MAC during mitral valve surgery; however, experience in the literature is limited.
Methods
We assessed 30-day and intermediate-term outcomes in 67 consecutive patients (mean age: 72 [SD 9] years; female sex: 65.7% [44/67]) with severe MAC who underwent mitral valve repair or replacement for mitral stenosis and/or regurgitation using CUSA from March 2021 through December 2024. Operations included isolated mitral valve replacement (41.8% [28/67]), isolated mitral valve repair (4.5% [3/67]), mitral and aortic valve replacement (37.3% [25/67]), mitral valve replacement with coronary bypass (6.0% [4/67]), and mitral and aortic valve replacement with coronary bypass (10.4% [7/67]). Intermediate survival was estimated using the Kaplan-Meier method.
Results
Mortality rate was 6.0% (4/67), stroke was 3.0% (2/67), and new postoperative atrial fibrillation was 29.0% (20/67). There were no atrioventricular groove ruptures. At a median echocardiographic follow-up time of 361 days (interquartile range [IQR] 112, 671), moderate paravalvular leak occurred in 3.0% (1/67). Mid-term all-cause mortality was 9.0% at a mean follow-up time of 42.5 (95% CI, 39.0, 46.0) months.
Conclusions
The use of CUSA to debride severe mitral annular calcification in patients undergoing mitral valve surgery is associated with acceptable short-term morbidity and mortality and durable intermediate-term results. This technique allows surgical intervention in patients who may otherwise be deemed prohibitive surgical risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiac Surgery, Hartford Healthcare Heart and Vascular Institute, Hartford, CT, 06106, United States.
- Cardiac Surgery, University of Connecticut School of Medicine, Farmington, CT, 06032, United States.
- Research Administration, Hartford Hospital, Hartford, CT, 06106, United States.
ORCID-Profile: David W Yaffee
Zitieren
APA
Jin, W., Hashim, S. W., Mckay, R. G., Mather, J., Collazo, S., & Yaffee, D. W. (2026). Early and Intermediate Outcomes of Cavitron Ultrasonic Surgical Aspiration to Treat Mitral Annular Calcification. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezag016
Vancouver
Jin W, Hashim SW, Mckay RG, Mather J, Collazo S, Yaffee DW. Early and Intermediate Outcomes of Cavitron Ultrasonic Surgical Aspiration to Treat Mitral Annular Calcification. European Journal of Cardio-Thoracic Surgery. 2026. doi:10.1093/ejcts/ezag016
BibTeX
@article{Jin2026,
author = {Jin, Wendy and Hashim, Sabet W and Mckay, Raymond G and Mather, Jeff and Collazo, Susan and Yaffee, David W},
title = {Early and Intermediate Outcomes of Cavitron Ultrasonic Surgical Aspiration to Treat Mitral Annular Calcification},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2026},
doi = {10.1093/ejcts/ezag016}
}
EUVIMED